Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 4
1968 4
1969 3
1970 1
1971 3
1972 4
1973 5
1974 2
1975 5
1976 2
1977 2
1979 4
1980 1
1981 4
1982 3
1983 2
1984 3
1985 4
1986 3
1987 3
1988 2
1989 3
1990 4
1991 6
1992 2
1993 8
1994 7
1995 9
1996 7
1997 8
1998 6
1999 12
2000 6
2001 10
2002 7
2003 13
2004 19
2005 15
2006 20
2007 33
2008 33
2009 31
2010 39
2011 32
2012 46
2013 55
2014 55
2015 46
2016 42
2017 41
2018 43
2019 47
2020 47
2021 41
2022 35
2023 25
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

794 results

Results by year

Filters applied: . Clear all
Page 1
Marfan's syndrome.
Judge DP, Dietz HC. Judge DP, et al. Lancet. 2005 Dec 3;366(9501):1965-76. doi: 10.1016/S0140-6736(05)67789-6. Lancet. 2005. PMID: 16325700 Free PMC article. Review.
Management of primary spontaneous pneumothorax: a review.
Wong A, Galiabovitch E, Bhagwat K. Wong A, et al. ANZ J Surg. 2019 Apr;89(4):303-308. doi: 10.1111/ans.14713. Epub 2018 Jul 5. ANZ J Surg. 2019. PMID: 29974615 Review.
This article will review the etiopathology, diagnosis and current management guidelines. It aims to improve clinical practice and compliance to the complexities of procedures involved in management....
This article will review the etiopathology, diagnosis and current management guidelines. It aims to improve clinical practice and com …
Pharmacologic Management of Aneurysms.
Lindeman JH, Matsumura JS. Lindeman JH, et al. Circ Res. 2019 Feb 15;124(4):631-646. doi: 10.1161/CIRCRESAHA.118.312439. Circ Res. 2019. PMID: 30763216 Free PMC article. Review.
Similarly, the concept of pharmaceutical aorta stabilization in Marfan syndrome is supported by a wealth of promising studies in the murine models of Marfan syndrome-related aortapathy. Although some clinical studies report successful medical st …
Similarly, the concept of pharmaceutical aorta stabilization in Marfan syndrome is supported by a wealth of promising studies …
Therapy of Marfan syndrome.
Judge DP, Dietz HC. Judge DP, et al. Annu Rev Med. 2008;59:43-59. doi: 10.1146/annurev.med.59.103106.103801. Annu Rev Med. 2008. PMID: 17845137 Review.
Marfan syndrome is a common inherited disorder of connective tissue caused by deficiency of the matrix protein fibrillin-1. ...Traditional medical therapies, such as beta-adrenergic receptor blockade, are used to slow pathologic aortic growth and decrease the risk o …
Marfan syndrome is a common inherited disorder of connective tissue caused by deficiency of the matrix protein fibrillin-1. .. …
Marfan syndrome-diagnosis and management.
Ammash NM, Sundt TM, Connolly HM. Ammash NM, et al. Curr Probl Cardiol. 2008 Jan;33(1):7-39. doi: 10.1016/j.cpcardiol.2007.10.001. Curr Probl Cardiol. 2008. PMID: 18155514 Review.
Marfan syndrome (MFS) is the most common inherited disorder of connective tissue that affects multiple organ systems. ...
Marfan syndrome (MFS) is the most common inherited disorder of connective tissue that affects multiple organ systems. ...
Marfan's syndrome and the heart.
Stuart AG, Williams A. Stuart AG, et al. Arch Dis Child. 2007 Apr;92(4):351-6. doi: 10.1136/adc.2006.097469. Arch Dis Child. 2007. PMID: 17376944 Free PMC article. Review.
Research on TGFbeta signalling and the potential treatment role of TGFbeta antagonists may lead to exciting new treatments, but the results of clinical trials are awaited. In managing the cardiovascular complications of Marfan's syndrome, the paediatrician has to walk a di …
Research on TGFbeta signalling and the potential treatment role of TGFbeta antagonists may lead to exciting new treatments, but the results …
Marfan Syndrome and Related Disorders: 25 Years of Gene Discovery.
Verstraeten A, Alaerts M, Van Laer L, Loeys B. Verstraeten A, et al. Hum Mutat. 2016 Jun;37(6):524-31. doi: 10.1002/humu.22977. Epub 2016 Mar 14. Hum Mutat. 2016. PMID: 26919284 Review.
Marfan syndrome (MFS) is a rare, autosomal-dominant, multisystem disorder, presenting with skeletal, ocular, skin, and cardiovascular symptoms. Significant clinical overlap with other systemic connective tissue diseases, including Loeys-Dietz syndrome (LDS), …
Marfan syndrome (MFS) is a rare, autosomal-dominant, multisystem disorder, presenting with skeletal, ocular, skin, and cardiov …
Genome-wide methylation patterns in Marfan syndrome.
van Andel MM, Groenink M, van den Berg MP, Timmermans J, Scholte AJHA, Mulder BJM, Zwinderman AH, de Waard V. van Andel MM, et al. Clin Epigenetics. 2021 Dec 11;13(1):217. doi: 10.1186/s13148-021-01204-4. Clin Epigenetics. 2021. PMID: 34895303 Free PMC article.
BACKGROUND: Marfan syndrome (MFS) is a connective tissue disorder caused by mutations in the Fibrillin-1 gene (FBN1). ...Associations between methylation levels and aortic diameters and presence or absence of 21 clinical features of MFS at baseline were analy …
BACKGROUND: Marfan syndrome (MFS) is a connective tissue disorder caused by mutations in the Fibrillin-1 gene (FBN1). ...Assoc …
Angiotensin receptor blockers and beta blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials.
Pitcher A, Spata E, Emberson J, Davies K, Halls H, Holland L, Wilson K, Reith C, Child AH, Clayton T, Dodd M, Flather M, Jin XY, Sandor G, Groenink M, Mulder B, De Backer J, Evangelista A, Forteza A, Teixido-Turà G, Boileau C, Jondeau G, Milleron O, Lacro RV, Sleeper LA, Chiu HH, Wu MH, Neubauer S, Watkins H, Dietz H, Baigent C; Marfan Treatment Trialists’ Collaboration. Pitcher A, et al. Lancet. 2022 Sep 10;400(10355):822-831. doi: 10.1016/S0140-6736(22)01534-3. Epub 2022 Aug 29. Lancet. 2022. PMID: 36049495 Free PMC article.
BACKGROUND: Angiotensin receptor blockers (ARBs) and beta blockers are widely used in the treatment of Marfan syndrome to try to reduce the rate of progressive aortic root enlargement characteristic of this condition, but their separate and joint effects are uncerta …
BACKGROUND: Angiotensin receptor blockers (ARBs) and beta blockers are widely used in the treatment of Marfan syndrome to try …
Marfan syndrome: A therapeutic challenge for long-term care.
Wagner AH, Zaradzki M, Arif R, Remes A, Müller OJ, Kallenbach K. Wagner AH, et al. Biochem Pharmacol. 2019 Jun;164:53-63. doi: 10.1016/j.bcp.2019.03.034. Epub 2019 Mar 27. Biochem Pharmacol. 2019. PMID: 30926475 Review.
Marfan syndrome (MFS) is an autosomal dominant genetic disorder caused by mutations in the fibrillin-1 gene. ...
Marfan syndrome (MFS) is an autosomal dominant genetic disorder caused by mutations in the fibrillin-1 gene. ...
794 results